SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
12743154
Source:
http://linkedlifedata.com/resource/pubmed/id/12743154
Search
Subject
(
93
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0026259
,
umls-concept:C0059985
,
umls-concept:C0079747
,
umls-concept:C0205195
,
umls-concept:C0441771
pubmed:issue
10
pubmed:dateCreated
2003-5-13
pubmed:abstractText
To determine the efficacy of combination fludarabine and mitoxantrone (FN) in untreated stages III and IV low-grade lymphoma. The major end point was to estimate progression-free survival (PFS) in all eligible patients.
pubmed:grant
http://linkedlifedata.com/resource/pubmed/grant/CA04919
,
http://linkedlifedata.com/resource/pubmed/grant/CA04920
,
http://linkedlifedata.com/resource/pubmed/grant/CA12213
,
http://linkedlifedata.com/resource/pubmed/grant/CA12644
,
http://linkedlifedata.com/resource/pubmed/grant/CA13612
,
http://linkedlifedata.com/resource/pubmed/grant/CA20319
,
http://linkedlifedata.com/resource/pubmed/grant/CA22433
,
http://linkedlifedata.com/resource/pubmed/grant/CA27057
,
http://linkedlifedata.com/resource/pubmed/grant/CA32102
,
http://linkedlifedata.com/resource/pubmed/grant/CA35119
,
http://linkedlifedata.com/resource/pubmed/grant/CA35176
,
http://linkedlifedata.com/resource/pubmed/grant/CA35178
,
http://linkedlifedata.com/resource/pubmed/grant/CA35192
,
http://linkedlifedata.com/resource/pubmed/grant/CA35261
,
http://linkedlifedata.com/resource/pubmed/grant/CA35281
,
http://linkedlifedata.com/resource/pubmed/grant/CA35431
,
http://linkedlifedata.com/resource/pubmed/grant/CA37981
,
http://linkedlifedata.com/resource/pubmed/grant/CA38926
,
http://linkedlifedata.com/resource/pubmed/grant/CA42028
,
http://linkedlifedata.com/resource/pubmed/grant/CA42777
,
http://linkedlifedata.com/resource/pubmed/grant/CA45377
,
http://linkedlifedata.com/resource/pubmed/grant/CA45450
,
http://linkedlifedata.com/resource/pubmed/grant/CA45560
,
http://linkedlifedata.com/resource/pubmed/grant/CA46136
,
http://linkedlifedata.com/resource/pubmed/grant/CA46282
,
http://linkedlifedata.com/resource/pubmed/grant/CA52654
,
http://linkedlifedata.com/resource/pubmed/grant/CA58415
,
http://linkedlifedata.com/resource/pubmed/grant/CA58416
,
http://linkedlifedata.com/resource/pubmed/grant/CA58658
,
http://linkedlifedata.com/resource/pubmed/grant/CA58686
,
http://linkedlifedata.com/resource/pubmed/grant/CA63850
,
http://linkedlifedata.com/resource/pubmed/grant/CA76462
,
http://linkedlifedata.com/resource/pubmed/grant/CA96429
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/8309333
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Mitoxantrone
,
http://linkedlifedata.com/resource/pubmed/chemical/Vidarabine
,
http://linkedlifedata.com/resource/pubmed/chemical/fludarabine
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0732-183X
pubmed:author
pubmed-author:BalcerzakStanley PSP
,
pubmed-author:ChapmanRobert ARA
,
pubmed-author:DakhilShaker RSR
,
pubmed-author:FisherRichard IRI
,
pubmed-author:GroganThomas MTM
,
pubmed-author:LanierKeith SKS
,
pubmed-author:LewDanikaD
,
pubmed-author:MillerThomas PTP
,
pubmed-author:Southwest Oncology Group
,
pubmed-author:SpiridonidisC HarrisCH
,
pubmed-author:VelasquezWilliam SWS
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
21
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1996-2003
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:12743154-Adult
,
pubmed-meshheading:12743154-Aged
,
pubmed-meshheading:12743154-Aged, 80 and over
,
pubmed-meshheading:12743154-Antineoplastic Combined Chemotherapy Protocols
,
pubmed-meshheading:12743154-Disease-Free Survival
,
pubmed-meshheading:12743154-Female
,
pubmed-meshheading:12743154-Humans
,
pubmed-meshheading:12743154-Lymphoma, Non-Hodgkin
,
pubmed-meshheading:12743154-Male
,
pubmed-meshheading:12743154-Middle Aged
,
pubmed-meshheading:12743154-Mitoxantrone
,
pubmed-meshheading:12743154-Neoplasm Staging
,
pubmed-meshheading:12743154-Survival Analysis
,
pubmed-meshheading:12743154-Treatment Outcome
,
pubmed-meshheading:12743154-United States
,
pubmed-meshheading:12743154-Vidarabine
pubmed:year
2003
pubmed:articleTitle
Combination of fludarabine and mitoxantrone in untreated stages III and IV low-grade lymphoma: S9501.
pubmed:affiliation
University of Texas Medical Branch, Galveston, USA. william.velasquez@usoncology.com
pubmed:publicationType
Journal Article
,
Clinical Trial
,
Research Support, U.S. Gov't, P.H.S.
,
Multicenter Study
,
Clinical Trial, Phase II